Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELICIT: Early Life Interventions for Childhood Growth
NCT03268902Phase 3Completed
- Sponsor
- Haydom Lutheran Hospital
- Start
- Sep 2017
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azithromycin, nitazoxanide, nicotinamide in stunting, Environmental Enteropathy (EED), sponsored by Haydom Lutheran Hospital. Started Sep 2017; status: completed.
02
Drugs
azithromycinnitazoxanidenicotinamide
03
Conditions
stuntingEnvironmental Enteropathy (EED)
Beyond the preview
Go deeper on NCT03268902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03268902.